The research, conducted on human cells, mice, and human lung cancer tissues, revealed that when ISG15 conjugates to SIRT1, it boosts SIRT1’s activity, encouraging tumor growth and reducing the effectiveness of a chemotherapy drug. This evidence concerns the gene SIRT1 and lung carcinoma.